{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:02:34Z","timestamp":1790622154969,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00228-022-03353-8","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T22:08:51Z","timestamp":1655762931000},"page":"1503-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["DRESS characteristics according to the causative medication"],"prefix":"10.1007","volume":"78","author":[{"given":"A.","family":"Chaabane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Ben","family":"Romdhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Ben","family":"Fadhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Ben","family":"Fredj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Chadly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-8076","authenticated-orcid":false,"given":"K.","family":"Aouam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"3353_CR1","unstructured":"Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI (2019) Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome - Search Results - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Liver+involvement+in+the+drug+reaction%2C+eosinophilia%2C+and+systemic+symptoms+syndrome&sort=jour&size=100. Accessed 14 Mar 2022"},{"key":"3353_CR2","unstructured":"Drug reaction with eosinophilia and systemic symptoms (DReSS): how far have we come?. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/30652265\/. Accessed 14 Mar 2022"},{"key":"3353_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/ijd.14174","volume":"57","author":"J Intarasupht","year":"2018","unstructured":"Intarasupht J, Kanchanomai A, Leelasattakul W et al (2018) Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement. Int J Dermatol 57:1187\u20131191. https:\/\/doi.org\/10.1111\/ijd.14174","journal-title":"Int J Dermatol"},{"key":"3353_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4103\/0366-6999.204104","volume":"130","author":"L Wang","year":"2017","unstructured":"Wang L, Mei X-L (2017) Drug reaction with eosinophilia and systemic symptoms: retrospective analysis of 104 cases over one decade. Chin Med J (Engl) 130:943\u2013949. https:\/\/doi.org\/10.4103\/0366-6999.204104","journal-title":"Chin Med J (Engl)"},{"key":"3353_CR5","unstructured":"Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/27936971\/. Accessed 14 Mar 2022"},{"key":"3353_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","volume":"155","author":"H Peyri\u00e8re","year":"2006","unstructured":"Peyri\u00e8re H, Dereure O, Breton H et al (2006) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 155:422\u2013428. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07284.x","journal-title":"Br J Dermatol"},{"key":"3353_CR7","doi-asserted-by":"publisher","first-page":"7863815","DOI":"10.1155\/2019\/7863815","volume":"2019","author":"PT Taweesedt","year":"2019","unstructured":"Taweesedt PT, Nordstrom CW, Stoeckel J, Dumic I (2019) Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review. Biomed Res Int 2019:7863815. https:\/\/doi.org\/10.1155\/2019\/7863815","journal-title":"Biomed Res Int"},{"key":"3353_CR8","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/jcm10184287","volume":"10","author":"D Jevtic","year":"2021","unstructured":"Jevtic D, Dumic I, Nordin T et al (2021) Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature. J Clin Med 10:4287. https:\/\/doi.org\/10.3390\/jcm10184287","journal-title":"J Clin Med"},{"key":"3353_CR9","doi-asserted-by":"publisher","unstructured":"Morikawa D, Hiraoka E, Obunai K, Norisue Y (2018) Myocarditis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and review of the literature. Am J Case Rep 19:978\u2013984. https:\/\/doi.org\/10.12659\/AJCR.909569","DOI":"10.12659\/AJCR.909569"},{"key":"3353_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","volume":"7","author":"AR Wolfson","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y et al (2019) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract 7:633\u2013640. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3353_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2016.04.001","author":"A H, T R, J K,","year":"2016","unstructured":"Hiransuthikul A, Rattananupong T, Klaewsongkram J\u00a0et al (2016) Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand. Allergology international\u202f: official journal of the Japanese Society of Allergology. https:\/\/doi.org\/10.1016\/j.alit.2016.04.001","journal-title":"Allergology international : official journal of the Japanese Society of Allergology"},{"key":"3353_CR12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/CMAR.S163391","volume":"10","author":"C-B Chen","year":"2018","unstructured":"Chen C-B, Wu M-Y, Ng CY et al (2018) Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies. Cancer Manag Res 10:1259\u20131273. https:\/\/doi.org\/10.2147\/CMAR.S163391","journal-title":"Cancer Manag Res"},{"key":"3353_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","volume":"82","author":"A Soria","year":"2020","unstructured":"Soria A, Bernier C, Veyrac G et al (2020) Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study. J Am Acad Dermatol 82:606\u2013611. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.036","journal-title":"J Am Acad Dermatol"},{"key":"3353_CR14","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1172\/JCI113798","volume":"82","author":"NH Shear","year":"1988","unstructured":"Shear NH, Spielberg SP (1988) Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82:1826\u20131832. https:\/\/doi.org\/10.1172\/JCI113798","journal-title":"J Clin Invest"},{"key":"3353_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC (1996) Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15:250\u2013257. https:\/\/doi.org\/10.1016\/s1085-5629(96)80038-1","journal-title":"Semin Cutan Med Surg"},{"key":"3353_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","volume":"68","author":"T Shiohara","year":"2019","unstructured":"Shiohara T, Mizukawa Y (2019) Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int 68:301\u2013308. https:\/\/doi.org\/10.1016\/j.alit.2019.03.006","journal-title":"Allergol Int"},{"key":"3353_CR17","doi-asserted-by":"publisher","unstructured":"Mehrholz D, Urban AE, Herstowska M et al (2017) A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms. Psychiatr Pol 51:1079\u20131093. https:\/\/doi.org\/10.12740\/PP\/74358","DOI":"10.12740\/PP\/74358"},{"key":"3353_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.alit.2016.09.003","volume":"66","author":"Y Kinoshita","year":"2017","unstructured":"Kinoshita Y, Saeki H, Asahina A et al (2017) Drug-induced hypersensitivity syndrome in Japan in the past 10 years based on data from the relief system of the Pharmaceuticals and Medical Devices Agency. Allergol Int 66:363\u2013365. https:\/\/doi.org\/10.1016\/j.alit.2016.09.003","journal-title":"Allergol Int"},{"key":"3353_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V et al (2011) The DRESS syndrome: a literature review. Am J Med 124:588\u2013597. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.017","journal-title":"Am J Med"},{"key":"3353_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/21548331.2018.1451205","volume":"46","author":"SK Behera","year":"1995","unstructured":"Behera SK, Das S, Xavier AS (1995) Selvarajan S (2018) DRESS syndrome: a detailed insight. Hosp Pract 46:152\u2013162. https:\/\/doi.org\/10.1080\/21548331.2018.1451205","journal-title":"Hosp Pract"},{"key":"3353_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B et al (2013) A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 168:555\u2013562. https:\/\/doi.org\/10.1111\/bjd.12125","journal-title":"Br J Dermatol"},{"key":"3353_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","volume":"62","author":"F Santiago","year":"2010","unstructured":"Santiago F, Gon\u00e7alo M, Vieira R et al (2010) Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62:47\u201353. https:\/\/doi.org\/10.1111\/j.1600-0536.2009.01659.x","journal-title":"Contact Dermatitis"},{"key":"3353_CR23","first-page":"357","volume":"137","author":"JR Sullivan","year":"2001","unstructured":"Sullivan JR, Shear NH (2001) The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 137:357\u2013364","journal-title":"Arch Dermatol"},{"key":"3353_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L et al (2007) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 156:609\u2013611. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"key":"3353_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245. https:\/\/doi.org\/10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"3353_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/all.12142","volume":"68","author":"K Brockow","year":"2013","unstructured":"Brockow K, Garvey LH, Aberer W et al (2013) Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper. Allergy 68:702\u2013712. https:\/\/doi.org\/10.1111\/all.12142","journal-title":"Allergy"},{"key":"3353_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/pds.4774","volume":"28","author":"DW Sim","year":"2019","unstructured":"Sim DW, Yu JE, Jeong J et al (2019) Variation of clinical manifestations according to culprit drugs in DRESS syndrome. Pharmacoepidemiol Drug Saf 28:840\u2013848. https:\/\/doi.org\/10.1002\/pds.4774","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3353_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/ijd.13667","volume":"56","author":"JY Lee","year":"2017","unstructured":"Lee JY, Lee S-Y, Hahm JE et al (2017) Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. Int J Dermatol 56:944\u2013951. https:\/\/doi.org\/10.1111\/ijd.13667","journal-title":"Int J Dermatol"},{"key":"3353_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4168\/aair.2019.11.1.90","volume":"11","author":"HY Jung","year":"2019","unstructured":"Jung HY, Park S, Shin B et al (2019) Prevalence and clinical features of drug reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: a retrospective cohort study. Allergy Asthma Immunol Res 11:90\u2013103. https:\/\/doi.org\/10.4168\/aair.2019.11.1.90","journal-title":"Allergy Asthma Immunol Res"},{"key":"3353_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","volume":"88","author":"M Ben M\u2019rad","year":"2009","unstructured":"Ben M\u2019rad M, Leclerc-Mercier S, Blanche P et al (2009) Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 88:131\u2013140. https:\/\/doi.org\/10.1097\/MD.0b013e3181a4d1a1","journal-title":"Medicine (Baltimore)"},{"key":"3353_CR31","first-page":"364","volume":"13","author":"GA Kennebeck","year":"2000","unstructured":"Kennebeck GA (2000) Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract 13:364\u2013370","journal-title":"J Am Board Fam Pract"},{"key":"3353_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","volume":"22","author":"C-C Chiou","year":"2008","unstructured":"Chiou C-C, Yang L-C, Hung S-I et al (2008) Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 22:1044\u20131049. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02585.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3353_CR33","first-page":"1315","volume":"132","author":"V Callot","year":"1996","unstructured":"Callot V, Roujeau JC, Bagot M et al (1996) Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities Arch Dermatol 132:1315\u20131321","journal-title":"Two different clinical entities Arch Dermatol"},{"key":"3353_CR34","doi-asserted-by":"publisher","unstructured":"Cardoso CS, Vieira AM, Oliveira AP (2011) DRESS syndrome: a case report and literature review. BMJ Case Rep bcr0220113898. https:\/\/doi.org\/10.1136\/bcr.02.2011.3898","DOI":"10.1136\/bcr.02.2011.3898"},{"key":"3353_CR35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169:1071\u20131080. https:\/\/doi.org\/10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"3353_CR36","unstructured":"A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/22211830\/. Accessed 14 Mar 2022"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03353-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T07:05:49Z","timestamp":1660115149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3353"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03353-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}